Study Objectives: Emerging evidence supports a multidimensional perspective of sleep in the context of health. The sleep health model, and composite sleep health score, are increasingly used in research. However, specific cut-off values that differentiate "good" from "poor" sleep, have not been empirically-derived and its relationship to cardiometabolic health is less-well understood. We empirically-derived cut-off values for sleep health dimensions and examined the relationship between sleep health and cardiometabolic morbidity. 
Introduction
Evidence is emerging to support the simultaneous consideration of multiple sleep parameters in the context of physical and mental health outcomes. For example, individuals with both insomnia and objectively-assessed short sleep duration have greater disease risk than individuals suffering from insomnia or short sleep duration alone 1 . In another study, individuals with sleep apnea symptoms and short sleep duration or a high number of daytime naps had increased cardiovascular risk, operationalized using a variant of the Framingham risk score 2 . A multidimensional approach to analyzing the relationship between sleep and health may provide complimentary information to that gleaned from consideration of individual dimensions of sleep, alone.
The sleep health model has been described as a multidimensional sleep/wake profile that promotes physical and mental well-being 3 . Consideration of sleep as a multidimensional construct also makes intuitive sense, as individual dimensions of sleep do not occur in isolation.
Based on this model, a single sleep health score is derived from measures of daytime alertness and sleep duration, timing, regularity, efficiency, and quality. These six sleep dimensions have been shown to load onto a single sleep health factor and demonstrate good construct validity 4 .
Sleep health scores outperformed a single measure of sleep duration in predicting poor selfreported health in ROC analysis and are associated with physical and mental health risk in a linear, graded fashion 5, 6 . Sleep health scores also appear to be sensitive to factors such as sex, race, education, and stress [5] [6] [7] .
Despite its increasing use in research, the optimal cut-off values used to differentiate "good" and "poor" across each sleep health dimension remain to be determined. For example, "good" sleep duration has been defined as 6-8 hours 3 , 7-8 hours 7 , and 7-9 hours 6 across different A c c e p t e d M a n u s c r i p t 5 studies, whereas "good" sleep efficiency has been defined as a sleep latency of < 30min 6 , < 30 minutes of wake time at night (including latency and wake after sleep onset) [3] [4] [5] , or a sleep efficiency of ≥ 85% 7 in independent reports. Whereas all published cut-off values are wellwrought and justified using a mixture of published findings and data from meta-analyses and large representative cohort studies, no study, to our knowledge, has attempted to empirically derive cut-off values for each sleep health dimension.
Aims of the current study were several-fold. First was to empirically derive cut-off values for each sleep health dimension in the sleep health model and to assess the degree to which cutoff values are robust across physical and mental health outcomes. Cut-off values are valuable for future research and clinical application only to the extent that they change little as a function of outcome. Using a second, independent sample, our second goal was to examine the degree to which sleep health, constructed using empirically derived cut-off values, associated with cardiometabolic morbidity, hypertension and diabetes. Cardiovascular diseases and metabolic disorders are among the leading causes of morbidity and mortality worldwide and carry enormous economic burden 8, 9 . As such, identification of risk factors for adverse cardiometabolic outcomes is crucial to prevention. Based on emerging evidence supporting a multidimensional sleep perspective and robust univariate associations between cardiometabolic outcomes and sleep duration [10] [11] [12] The MIDUS Refresher study (2011-2014) recruited a national probability sample of adults with the goal of replenishing the original MIDUS I cohort. The MIDUS Refresher Biomarker Study (2012-2016) was conducted using the same methods as the MIDUS II Biomarker study so that data could be combined to strengthen cross-sectional and future longitudinal analyses. Additional details regarding the methods and samples have been published elsewhere 19, 20 . In both studies, concurrent measurement of sleep using daily diary and wrist actigraphy was undertaken at the University of Wisconsin-Madison study site only, limiting the size of each sample. Only participants having concurrent daily diary and actigraphy data were analyzed. After exclusions for other missing data, the final analytical sample was 700 ( Figure 1 ). Approval from appropriate Institutional Review Boards was granted for this study and all participants gave informed consent prior to participation.
Procedure
After completion of the Biomarker Study visit, participants were invited to participate in a 7-day sleep study. Following consent, participants were sent home with instructions and study materials and given a reminder phone call by trained research staff the day before the study was A c c e p t e d M a n u s c r i p t 7 to begin. Participants were instructed to wear a wrist actigraph and complete a daily sleep diary for seven consecutive days. The diaries were pre-labelled with the dates upon which each participant was supposed to complete each diary entry. All studies began on a Tuesday at 0700
hours and ended at the same time the following Tuesday. Participants then mailed the study materials back to the investigators in pre-paid envelopes.
Daily Sleep Diary & Pittsburgh Sleep Quality Index
Participants completed the Pittsburgh Sleep Quality Index (PSQI) 21 on day one of the laboratory visit as part of a large questionnaire battery. For the purposes of this study, the two items concerning sleep duration and sleep latency were analyzed. The daily sleep diary comprised a morning and evening section. In the morning, participants reported on their previous night's sleep. Questions included, among others, items related to timing of sleep, nighttime awakenings, sleep difficulties, and sleep quality. In the evening before going to bed, participants reported on that day's activities including daytime alertness. Diary data was entered into SPSS using a blind double entry verification system and discrepancies were adjudicated using standardized procedures.
Actigraphy
The Actiwatch system (Models 64 and 2; Philips Corporation, Andover, MA) was used for both Biomarker studies to measure activity, via motion-sensor, throughout the duration of the sleep study. Actiwatches were programmed by staff to begin collecting data at 0700 hours on Tuesday and collected activity data in 30-second epochs until study conclusion. Actiware software (versions 5 or 6) was used for data analysis. A standard stepwise procedure was used to determine the rest interval. First, the rest interval was defined offline based on responses from the daily sleep diary. Second, when diary data were not available, events markers were used to A c c e p t e d M a n u s c r i p t 8 define the rest interval if event markers appeared to be reliable. Third, if data was missing and event markers were found to be unreliable, rest intervals were imputed using the following rules: a) for a missing weekday, the rest interval was imputed using at least 3 other adjacent weekdays, b) for a missing weekend, the rest interval was imputed using the other weekend day 19, 20 . In the combined analytical sample (N = 700), diary data was used in 668 cases (95.4%), event markers
were used in 40 cases (5.7%) and some degree of imputation was used in 32 cases (4.6%). Once the rest interval was defined, Actiware software calculated summary statistics using a wake activity threshold of 40 and an epoch length of 30 seconds.
Cardiometabolic Outcomes
Cardiometabolic outcomes were derived from several measures including, self-reported physician diagnoses, current medication use, and blood panel values. Participants self-reported physician diagnoses of heart disease, hypertension, stroke, and diabetes and current medications during a medical history interview. Participants were first asked whether they had any of the outcomes of interest. If participants responded "yes," a follow-up question probed whether the outcome was diagnosed by a physician. For the purposes of this study, participants were only considered to have the diagnosis if it was reported to have been diagnosed by a physician.
Diagnoses associated with medication use were coded using ICD9 classifications. Finally, hemoglobin A1c was measured from a fasting blood sample taken in the morning on day two of the laboratory visit and analyzed using an immunoturbidometric assay 19, 20 . Dichotomous outcome variables were created for each outcome (1= diagnosis present, 0 = diagnosis absent).
This coding scheme was adopted because we were interested in quantifying the degree to which good sleep health decreased risk for cardiometabolic morbidity. If a participant endorsed a physician diagnosis or reported medication use consistent with a diagnosis the diagnosis was A c c e p t e d M a n u s c r i p t 9 considered present. In the case of diabetes, if a participant also had an HbA1c value greater than 6.5%, 22 diabetes was considered present, even if a physician diagnosis and medication use were absent. For omnibus analysis, a dichotomous total cardiometabolic morbidity variable was created that quantified the number of participants who had any of the outcomes of interest. In follow-up analyses, hypertension and diabetes were examined individually. The low prevalence of stroke and heart disease ( Table 1) in the MIDUS Refresher sample precluded individual analysis of these outcomes.
Traditional Cardiometabolic Risk Factors
Sociodemographic and behavioral risk factors included age, sex (male/female), body mass index (BMI), race, education, smoking status, alcohol consumption, and physical activity 23, 24 . Height and weight were measured by study staff and BMI calculated as kg/m 2 . It should be noted that BMI and BMI-squared were both used as covariates as reports have suggested that high and low BMI carry risk 25 . Race was coded as white and non-white, and education was defined along 5 categories: less than high school, high school diploma, some college, bachelor's degree, and graduate school/terminal degree. Smoking status was determined based upon responses to the question "Have you ever smoked regularly," coded dichotomously.
Alcohol consumption over the past month was defined across 4 categories: never to <1 day/week, 1-2 days/week, 3-4 days/week, and 5+ days/week. Participants were dichotomized (yes/no) on physical activity based on their response to a question asking whether they engaged in at least 20 minutes of exercise or physical activity 3 times a week. As depression has been linked with increased cardiometabolic risk 26, 27 , depression history, operationalized as a selfreported physician diagnosis of depression was used as a covariate. Depression history was used instead of self-report measures because it was more strongly associated with out outcomes of A c c e p t e d M a n u s c r i p t 10 interest. Finally, total cholesterol from a fasting blood sample was considered a biological risk factor.
Sleep Health Construction
The sleep health model holds that sleep is multidimensional and comprises six dimensions: daytime alertness and sleep quality, timing, regularity, efficiency, and duration.
Dimensions were derived from self-report and actigraphy data. Daytime alertness and sleep quality were self-reported on a 5-point Likert-type scale in daily sleep diaries. Anchor words for alertness and sleep quality were 1 (most alert) -5 (not at all alert) and 1 (very good) -5 (very poor), respectively. Sleep timing was operationalized as the actigraphy-derived sleep midpoint, occurring midway between sleep onset and offset. The variability in sleep midpoint across the week, quantified using standard deviation, represented sleep regularity for each participant.
Finally, standard measures of sleep efficiency and duration were quantified using actigraphy data.
Analytic Strategy
The larger MIDUS II sample was used to derive cut-off values. Receiver operating characteristic (ROC) curves were generated for each sleep health variable to assess sensitivity, specificity, and area under the curve (AUC). For all six sleep health dimensions, average values for the week were calculated from daily values to achieve measures of habitual sleep. The primary outcome measure was total cardiometabolic morbidity and cut-off values from this ROC analysis were carried over to future analyses. However, to assess the degree to which cut-off values varied as a function of outcome, supplementary ROC analyses using hypertension, diabetes, and self-reported physician diagnosis of depression as outcome variables were undertaken. Sensitivity was the probability of classifying a participant with a cardiometabolic predictor and cardiometabolic morbidity was expected (e.g., sleep duration and timing), predictor data was median-centered and squared to achieve linearity with the outcome variable. Nonlinear predictors have been shown to violate the binormal assumption of ROC analysis and produce sigmoidal ROC curves that tend to be biased toward null associations. Transforming the predictor by first median-centering and then squaring has been shown to achieve linearity with outcome variables, conform with the binormal assumption of ROC analysis, produce a typical concave-down ROC curve, and significantly reduce bias. 29 In the MIDUS Refresher sample, sleep health scores were calculated using cut-off values derived from the MIDUS II sample. All sleep health dimensions were first centered using the respective cut-off value, producing a new variable that could be interpreted as "distance" from the cut-off value. Next, all sleep health dimensions were transformed to z-scores to achieve a uniform scale across the dimensions. Z-scores were coded such that greater values indicated better sleep health. Finally, all six of the individual sleep health dimensions z-scores were summed, creating a total sleep health score.
Correlation analysis and analysis of variance (ANOVA) were used to test the relationship between sleep health scores and cardiometabolic risk factors. Interrelationships between the continuous measures of the sleep health dimensions were tested using Spearman's correlation.
A c c e p t e d M a n u s c r i p t Analyses were carried out using SPSS version 25 (IBM Analytics, New York, NY).
Results

Participants
Participant characteristics for both samples are shown in Table 1 . Overall, samples were comparable, with the exception of age, education, exercise, and number of smoking participants.
The MIDUS Refresher sample was significantly younger, tended to be more highly educated, exercise less, and had fewer smokers. There was no significant difference between the groups in cardiometabolic disease prevalence or sleep health dimensions. Table 1 ). The cut-off value for sleep quality and sleep efficiency varied little across outcomes, between 2.6-2.8 and 78%-83% for quality and efficiency, respectively. Across Table 2) . Sleep health was significantly related to age (r =.16, p = .008), as age increased, sleep health scores increased (i.e., better sleep health). Importantly, sleep health cut-off scores were similar when compared across "younger" (n = 209; < 56 years) and "older" (n = 223; ≥56 years) subgroups using a median split (Supplementary Table 3 
Sleep Health and Cardiometabolic Morbidity
In unadjusted analyses, better sleep health was significantly associated with lower odds of total cardiometabolic morbidity or hypertension alone ( Despite the small time window, sleep timing was the sleep health dimension with the greatest percentage of participants falling in the "poor" category. Previous studies have used 30 min as a cut-off value to define sleep regularity 7 . In other words, sleep regularity can be considered "good" if sleep midpoint varies by less than 30min, on average, across a given number of nights.
Our results suggest that 65min is an appropriate cut-off value for differentiating "good" and "poor" sleep regularity. Although this window is wider than previously published values, 65min
is approximately the width of the time window we found appropriate to define sleep timing. We found that a sleep efficiency of 83% corresponded most closely with a previously published study of childhood trauma and sleep health, where a value of 85% was used, based on the clinical goal of achieving 85% sleep efficiency in those receiving treatment for insomnia 7 . Other studies have used sleep latency and wake after sleep onset to operationalize the sleep efficiency dimension of sleep health. In these studies, less than 30 minutes of sleep latency 6 or combined sleep latency and wake after sleep onset 3-5 is considered to be consistent with "good" sleep continuity. The cut-off values for sleep duration were notably shorter than previous reports. Our results indicated that 5hrs 20min-7hrs 6min represented "good" sleep duration whereas other studies have used values of 7-8hrs 7 , 6-8hrs [3] [4] [5] , and 7-9hrs 6 . However, actigraphy was used to measure sleep in the present study, while sleep durations were self-reported in prior studies of sleep health. Thus, methodological differences may account for these somewhat discrepant results. Methods used to quantify subjective reports of alertness and satisfaction vary widely across studies, making comparisons difficult. Whereas the current study and one other 6 used a 5-point Likert type scale, some studies have used a 0-2 Likert type scale [3] [4] [5] or a 100-point visual analog scale 7 . Still others have used standardized questionnaires such as the Epworth Sleepiness
Scale and its cut-off value of 10 to operationalize alertness.
Several factors must be considered when considering the validity of these cut-off values.
First, these cut-off values were also derived using actigraphy (except subjective alertness and quality). As actigraphy and subjective measures of sleep capture somewhat different bands of variance 31 it is possible that different cut-off values will arise as a function of methodology.
Second, the sample was comprised of midlife adults from a limited region of the United States.
The degree to which these values will generalize across diverse samples in unknown. The values reported here represent the first attempt to empirically derive a set of clinically-relevant sleep health cut-off values. The finding that cut-off values were relatively robust across physical and mental health outcomes is encouraging and suggests that these values may represent a reliable boundary across which dysregulated sleep may confer sleep. Future research will determine the degree to which these values will remain robust across sleep recording methodologies and populations.
A c c e p t e d M a n u s c r i p t
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The finding that greater sleep health was associated with lower odds of reporting cardiometabolic morbidity adds to the emerging findings relating poor sleep health to clinically significant symptoms of depression 6 and poor self-reported health 4 This may be the result of older individuals having fewer sleep constraints than younger individuals. Alternatively, it is possible that a survivorship-type bias may be responsible for such a discrepant result. If so, this would lead to an underestimation of the true relationship between sleep health and cardiometabolic morbidity.
To conclude, using two independent samples, the present study empirically-derived cutoff values for the six individual dimensions of sleep that comprise sleep health and showed that they are relatively stable across physical and mental health outcomes. In a separate sample, good sleep health was cross-sectionally associated with reduced odds of cardiometabolic morbidity and hypertension. These results contribute to the ongoing development of the sleep health model and add to the emerging research supporting a multidimensional perspective of sleep and health. , respectively. Chisquare analysis for race was conducted using the dichotomous coding scheme described in the text. c Includes participants endorsing Native American, Alaskan/Eskimo, Asian, Hawaiian/Pacific Island, or other ethnic backgrounds. 
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